Health Care Up on Defensive Bias -- Health Care Roundup

Health-care companies rose as traders bought into the defensive sector ahead of key economic and inflation data.

Sanofi shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key goal and U.S. regulators signaling a decision on the drug would be delayed again.

Obesity-drug maker Eli Lilly shares rose by more than 3%, testing all-time highs, amid optimism about demand.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

12-15-25 1753ET